Analysts Set Bristol-Myers Squibb (NYSE:BMY) Target Price at $57.86
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) has been assigned a consensus rating of “Hold” from the nineteen brokerages that are covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, four have assigned a buy rating and two have assigned a strong […]
